 |
 |
|
|
Preventing, diagnosing, treating, and curing diseases caused by tobacco use is the primary objective of the King Program, and the results achieved since the Program’s inception are impressive. The purpose of the Bankhead-Coley Program is to "advance progress toward cures for cancer..." With each new study, scientists come closer to the end goals of the King and Bankhead-Coley Programs. Grantees in these Programs are adding significant data to the body of knowledge that will eventually provide cures to many tobacco-related diseases and cancer. We have made progress in understanding the type of pharmacology that will help smokers quit using tobacco and finding correlations between damaged DNA and cancer, smoking and developmental disabilities, and we continue to increase our awareness and understanding of the social influences on smoking behaviors. What makes these research grants worthy of continued support is the exciting advances that have already been made.
To view a report of current active grantee statistics clicking on the following link: Active Grants Report.
The profiles of the grantees can be found below in Grantee Information.
To view competition outcomes for the Florida Biomedical Research Program, click on one of the following reports:
Competition Outcomes
Grants Awarded By Institution
Application and Award History By Institution
King Program grantees continue to produce valuable insights into diseases related to tobacco use. Grantees are leveraging their King Program research, bringing federal dollars to Florida for the study of pulmonary and cardiovascular disease, stroke, cancer, and nicotine addiction. Additional funding earned by King grantees exceeded $160 million as of October 2010, 97 percent of which was from outside Florida. In addition, their research is creating and sustaining jobs and ensuring a vital workforce for tomorrow.
The 2010 Annual Report features grantees’ accomplishments and discoveries with particular promise. The following profiles, included in the 2010 report, illustrate how Program grantees are bringing new ideas to the forefront of diagnosis, treatment, and prevention efforts for diseases related to tobacco use. The group is as varied as their successes and includes medical school professors, heart surgeons, radiation oncologists, and pediatricians to name a few.
- Dr. Matthias Salathe, 2005 TSP grantee from the University of Miami (p. 10);
- Dr. Keith Brew, 2008 TSP grantee from the Florida Atlantic University (p. 10);
- Dr. Joy Lincoln, 2007 NIR grantee from the University of Miami (p. 11);
- Dr. David Lee, 2006 TSP grantee from the University of Miami (p. 12);
- Dr. Hengli Tang, 2006 NIR grantee from the Florida State University (p. 12);
- Dr. Shyam Mohapatra, 2003 SBTT (TTCP) and 2007 TSP grantee, from the University of South Florida (p. 13);
- Dr. Valentina Echeverria-Moran, 2007 NIR grantee from the Bay Pines VA Healthcare System (p. 14);
- Dr. Igor Alabugin, 2009 TTCP grantee from Florida State University (p. 15);
- Dr. Tatyana Zhukov, 2007 NIR grantee from the Moffitt Cancer Center & Research Institute (p. 16);
- Dr. Melvyn Tockman, 2009 TTCP grantee from the Moffitt Cancer Center & Research Institute (p. 16);
- Dr. Mary Gerend, 2007 NIR grantee from Florida State University (p. 17);
- Dr. Steven Ames, 2009 RC1 grantee from the Mayo Clinic (p. 18);
- Dr. Maria Jose Miguez, 2010 RPG grantee from the Florida International University (p. 19);
- Dr. Alfred Lewin, 2009 SIG grantee from the University of Florida (p. 20);
- Dr. Ming Su, 2007 NIR grantee from the University of Central Florida (p. 20);
- Dr. Jason Lang, 2009 NIR grantee from the Nemours Children’s Clinic (p. 21);
- Dr. Sanford Meeks, 2008 TSP grantee from the M.D. Anderson Cancer Center (p. 23);
- Dr. Keith Webster, 2007 TSP grantee from the University of Miami (p. 23);
- Dr. Thomas Beaver, 2009 RC1 grantee from the University of Florida (p. 24);
- Dr. Duane Eichler, 2008 Bridge grantee from the University of South Florida (p. 24);
- Dr. Roger Papke, 2010 RPG grantee from the University of Florida (p. 25);
- Dr. Vincent Moy, 2009 SIG grantee from the University of Miami (p. 26);
- Dr. Alison Willing, 2007 Bridge grantee from the University of South Florida (p. 26);
- Dr. Marina Casalino-Matsuda, 2007 NIR grantee from the University of Miami (p. 27);
- Dr. Eric Bennett, 2007 Bridge grantee from the University of South Florida (p. 27); and
- Dr. Dana Rollison, 2006 NIR grantee from the Moffitt Cancer Center & Research Institute (p. 28).
Click on the follow link to access the King Program 2010 Annual Report . The grantee profiles begin on page 15 of the Annual Report. The report also includes quotes and statements from many other current grantees about their research and the Program.
The Bankhead-Coley Program completed its fourth full year of operation in 2010, with the active portfolio growing to 97, more than double December 2009 figures. Additional funding attracted from outside the state reached nearly $109 million as of October 2010, more than three times the value of all awards made through mid-2009.
The 2010 Annual Report aggregates the impact of Program awards in building Florida’s capacity for cancer research and bolstering the state’s technology-based economy. Perhaps most importantly, it details the accomplishments of individual grantees and provides glimpses into some of the many laboratories across Florida, “where the rubber meets the road,” where talented research teams are turning Bankhead-Coley grants into important cancer discoveries. Grantees featured in the 2010 report include the following:
- Dr. Yi Qiu, 2007 NIR grantee from University of Florida (p. 15);
- Dr. Takeo Urakami, 2010 PRF grantee from Sanford-Burnham Medical Research Institute (p. 15);
- Dr. Quentin Felty, 2009 NIR grantee from Florida International University (p. 16);
- Dr. Qun Huo, 2009 Bridge grantee from University of Central Florida (p. 16);
- Dr. Peter Storz, 2007 NIR grantee from Mayo Clinic (p. 16);
- Dr. Dmitry Gabrilovich, 2006 Bridge grantee from Moffitt Cancer Center & Research Institute (p. 17);
- Dr. Suming Huang, 2007 NIR grantee from University of Florida (p. 17);
- Dr. Jennifer J. Hu, 2010 RPG grantee from University of Miami (p. 19);
- Dr. Lisa Baumbach, 2009 RC1 grantee from University of Miami (p. 19);
- Dr. Jatinder Palta, 2009 Bridge and RC1 grantee from University of Florida (p. 20);
- Dr. Mia Liza Lustria, 2007 NIR grantee from Florida State University (p. 20);
- Dr. Joyce Slingerland, 2009 SPORE grantee from University of Miami (p. 23);
- Dr. Silvia Tornaletti, 2008 NIR grantee from University of Florida (p. 23);
- Dr. Esther Guzmán, 2009 NIR grantee from Florida Atlantic University (p. 24);
- Dr. John Koomen, 2006 SIG grantee from Moffitt Cancer Center & Research Institute (p. 24);
- Dr. Jin Cheng, 2007 Bridge grantee from Moffitt Cancer Center & Research Institute (p. 24);
- Dr. Yoshimi Shibata, 2006 grantee from Florida Atlantic University (p. 25);
- Dr. John Copland, 2007 Bridge grantee from Mayo Clinic (p. 25);
- Dr. John Goldberg, 2009 NIR grantee from University of Miami (p. 27);
- Dr. Benjamin Djulbegovic, 2009 RC1 grantee from University of South Florida (p. 27);
- Dr. Erin Siegel, 2009 NIR grantee from Moffitt Cancer Center & Research Institute (p. 27);
- Dr. Jeffrey Weber, 2008 Bridge grantee from Moffitt Cancer Center & Research Institute (p. 28);
- Dr. Margaret Byrne, 2007 SEP grantee from University of Miami (p. 28); and
- Dr. Karen Moffitt, 2007 SEP grantee from University of South Florida (p. 28).
Click on the follow link to access the Bankhed-Coley Program 2010 Annual Report . The profiles begin on page 15 of the annual report. The annual report also includes quotes and statements from many other current grantees about their research and the Program.
|
 |
 |
|